Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

BACKGROUND: Cardiovascular risk remains increased despite optimal low density lipoprotein cholesterol (LDL-C) level induced by intensive statin therapy. Therefore, recent guidelines recommend non-high density lipoprotein cholesterol (non-HDL-C) as a secondary target for preventing cardiovascular eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Jun, Ji Eun, Jeong, In-Kyung, Yu, Jae Myung, Kim, Sung Rae, Lee, In Kye, Han, Kyung-Ah, Choi, Sung Hee, Kim, Soo-Kyung, Park, Hyeong Kyu, Mok, Ji-Oh, Lee, Yong-ho, Kwon, Hyuk-Sang, Kim, So Hun, Kang, Ho-Cheol, Lee, Sang Ah, Lee, Chang Beom, Choi, Kyung Mook, Her, Sung-Ho, Shin, Won Yong, Shin, Mi-Seung, Ahn, Hyo-Suk, Kang, Seung Ho, Cho, Jin-Man, Jo, Sang-Ho, Cha, Tae-Joon, Kim, Seok Yeon, Won, Kyung Heon, Kim, Dong-Bin, Lee, Jae Hyuk, Lee, Moon-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043989/
https://www.ncbi.nlm.nih.gov/pubmed/31237134
http://dx.doi.org/10.4093/dmj.2018.0265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043989/
https://www.ncbi.nlm.nih.gov/pubmed/31237134
http://dx.doi.org/10.4093/dmj.2018.0265

Ejemplares similares